Proposed Standards and Regulatory Mechanisms for New Homeopathic Drug Development

Abstract

Introduction Researchers working with new insights and new targets in new drug discovery in the homeopathy space observe that the path of drug-development and market authorisation has been less travelled and the pathway is not yet well-mapped. The need of the time is to define clear guidelines and regulatory mechanisms to facilitate the process of new drug discovery.

Overview The article is about the proposed methods for identifying the new homeopathic substances for therapeutic use. An overview of the current regulations for drug development in India is discussed in this article. Method of new drug development in homeopathy, standards and regulatory mechanism for approval of new drugs are proposed with few illustrations and references. An introductory plan, based on the perspective and experience of researcher, practitioner, academician and inventor for drug discovery is proposed.

Discussion An urgent need for setting up the guidelines for new drug discovery has been identified and a basic proposition is made for the same, suggesting practical, pragmatic and achievable measures, and independent regulatory body to encourage drug development and research.

Keywords

regulation - new homeopathy drugs - standards - guidelines - approval

Publikationsverlauf

Artikel online veröffentlicht:
31. Dezember 2021

• References

• 1 The Drugs and Cosmetics act and rules, The Drugs and Cosmetics act, 1940 (23 OF 1940) (As amended up to the 30th June 2005) and The Drugs and Cosmetics Rules, 1945 (As amended up to the 30th June 2005. Ministry of Health and Family Welfare (Department of Health)
• 2 Status of Homeopathy in the Drugs and Cosmetics Act and rules. Available from: https://www.nhp.gov.in/Status-of-Homeopathy-in-the-Drugs-and-Cosmetic-Act-and-rules_mtl. [Last accessed on 2018 May 27]
• 3 The Drugs and Cosmetics act and rules, The Drugs and Cosmetics act, 1940 (23 OF 1940) (As amended up to the 30th June 2005) and The Drugs and Cosmetics Rules, 1945 (As amended up to the 30th June 2005. Ministry of Health and Family Welfare (Department of Health). Subs. G.S.R. 680 (E), dt. 5–12–1980. P. 42
• 4 Chikramane PS, Suresh AK, Bellare JR, Kane SG. Extreme homeopathic dilutions retain starting materials: a nanoparticulate perspective. Homeopathy 2010; 99 (04) 231-242
• 5 Hahnemann S. Organon of Medicine. 6th edition. (Translated by William Boericke). New Delhi: B Jain Publishers; ; Reprint; 1979: 111
• 6 Hahnemann S. Organon of Medicine, Aphorism 269. 6th edition. New Delhi: B Jain Publishers; ; reprint; 1979: 288-290
• 7 Hahnemann S. Organon of Medicine, Aphorism 143–145. 6th edition. New Delhi: B Jain Publishers; ; reprint; 1979: 210-212
• 8 Boericke W. Homeopathic Materia Medica. Presented by Médi-T. Available from: http://www.homeoint.org/books/boericmm/index.htm. [Last accessed on 2018 Dec 05]
• 9 Shah R. Standardization of the potentizing machine and quantification of impact of potentization. Indian J Res. Homoeopathy 2016; 10: 126-132
• 10 Homeopathic Medicinal Product Working Group (HMPWG). Heads of Medicines Agencies (HMA) consolidated list of FSD. Available from: https://www.hma.eu/fileadmin/dateien/Human_Medicines/01-About_HMA/Working_Groups/HMPWG/2018_12_HMPWG_4th_List_FSD_final_20181217.pdf. [Last accessed on 2018 Dec 05]
• 11 Shah R. Quantitative and qualitative pathogenetic indices for review of data derived from homeopathic pathogenetic trials. Homeopathy 2018; 107 (04) 274-279
• 12 An overview of the current status of New Homeopathic Drug Development (under review process).